Jamie C L Chuvalo-Abraham, David Harris, Hyunho Kang, Chiamaka U Ukachukwu, Catherine Guarino
{"title":"Evaluating the color stability of titanium dioxide-free film coats under environmental and light stress.","authors":"Jamie C L Chuvalo-Abraham, David Harris, Hyunho Kang, Chiamaka U Ukachukwu, Catherine Guarino","doi":"10.1080/10837450.2025.2489005","DOIUrl":null,"url":null,"abstract":"<p><p>Titanium dioxide (TiO<sub>2</sub>) is an opacifier/colorant in tablet film coatings and capsule shells. Recently, questions about its safety have raised concerns that it may be banned from medicinal products in the European Union (EU); however, little information exists on alternatives to enable the pharmaceutical industry to pivot. This study evaluated color stability of film coats containing alternate opacifiers, calcium carbonate (CaCO<sub>3</sub>) and rice starch. Placebo tablets were coated with film coating systems containing different polymers (hydroxypropyl methylcellulose (HPMC) or polyvinyl alcohol (PVA)), opacifiers (CaCO<sub>3</sub>, rice starch, or TiO<sub>2</sub>) and pigments (FD&C Blue No. 2, iron oxides, or non-pigmented); the coated tablets were exposed to environmental stress (temperature/humidity) and light stress and color changes were quantified spectrophotometrically.The HPMC-formulated coats containing CaCO<sub>3</sub> or rice starch showed comparable stability to TiO<sub>2</sub>. The PVA-based coats containing FD&C Blue No. 2 or iron oxide colorants exhibited color changes when exposed to elevated temperature/humidity, which were more pronounced with CaCO<sub>3</sub> than with TiO<sub>2</sub>. No meaningful color changes were observed under white or UV light stress for any coat. This study demonstrated PVA coating systems pose a stability risk, whereas these alternate opacifiers presented an overall low color stability risk, offering potential TiO<sub>2</sub> alternatives.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1-10"},"PeriodicalIF":2.6000,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Development and Technology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10837450.2025.2489005","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Titanium dioxide (TiO2) is an opacifier/colorant in tablet film coatings and capsule shells. Recently, questions about its safety have raised concerns that it may be banned from medicinal products in the European Union (EU); however, little information exists on alternatives to enable the pharmaceutical industry to pivot. This study evaluated color stability of film coats containing alternate opacifiers, calcium carbonate (CaCO3) and rice starch. Placebo tablets were coated with film coating systems containing different polymers (hydroxypropyl methylcellulose (HPMC) or polyvinyl alcohol (PVA)), opacifiers (CaCO3, rice starch, or TiO2) and pigments (FD&C Blue No. 2, iron oxides, or non-pigmented); the coated tablets were exposed to environmental stress (temperature/humidity) and light stress and color changes were quantified spectrophotometrically.The HPMC-formulated coats containing CaCO3 or rice starch showed comparable stability to TiO2. The PVA-based coats containing FD&C Blue No. 2 or iron oxide colorants exhibited color changes when exposed to elevated temperature/humidity, which were more pronounced with CaCO3 than with TiO2. No meaningful color changes were observed under white or UV light stress for any coat. This study demonstrated PVA coating systems pose a stability risk, whereas these alternate opacifiers presented an overall low color stability risk, offering potential TiO2 alternatives.
二氧化钛(TiO2)是片剂、包衣和胶囊外壳的不透明/着色剂。最近,关于其安全性的问题引起了人们的担忧,即它可能被禁止在欧盟(EU)的医药产品中使用;然而,关于使制药业能够转向的替代方案的信息很少。本研究评估了含有替代不透明剂、碳酸钙(CaCO3)和大米淀粉的薄膜涂层的颜色稳定性。安慰剂片剂涂有含有不同聚合物(羟丙基甲基纤维素(HPMC)或聚乙烯醇(PVA))、不透明剂(CaCO3、大米淀粉或TiO2)和颜料(FD&C Blue No. 2、氧化铁或无色素)的薄膜涂层系统;将包衣片暴露于环境胁迫(温度/湿度)下,用分光光度法定量测定光胁迫和颜色变化。含有CaCO3或大米淀粉的hpmc配制的涂层表现出与TiO2相当的稳定性。含有FD&C Blue No. 2或氧化铁着色剂的pvm涂层在高温/高湿度下呈现出颜色变化,CaCO3比TiO2更明显。在白光或紫外光胁迫下,没有观察到任何涂层的明显颜色变化。该研究表明,PVA涂层系统存在稳定性风险,而这些替代不透明剂总体上具有较低的颜色稳定性风险,为TiO2提供了潜在的替代品。
期刊介绍:
Pharmaceutical Development & Technology publishes research on the design, development, manufacture, and evaluation of conventional and novel drug delivery systems, emphasizing practical solutions and applications to theoretical and research-based problems. The journal aims to publish significant, innovative and original research to advance the frontiers of pharmaceutical development and technology.
Through original articles, reviews (where prior discussion with the EIC is encouraged), short reports, book reviews and technical notes, Pharmaceutical Development & Technology covers aspects such as:
-Preformulation and pharmaceutical formulation studies
-Pharmaceutical materials selection and characterization
-Pharmaceutical process development, engineering, scale-up and industrialisation, and process validation
-QbD in the form a risk assessment and DoE driven approaches
-Design of dosage forms and drug delivery systems
-Emerging pharmaceutical formulation and drug delivery technologies with a focus on personalised therapies
-Drug delivery systems research and quality improvement
-Pharmaceutical regulatory affairs
This journal will not consider for publication manuscripts focusing purely on clinical evaluations, botanicals, or animal models.